LMR Partners’s GSK GSK Stock Holding History

LMR Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.1M	Buy	+980,479	New	+$53.1M	0.12%	89
2025 Q4	–	Sell	-384,302	Closed	-$17.9M	–	1602
2025 Q3	$16.6M	Hold	384,302	–	–	0.07%	208
2025 Q2	$14.8M	Hold	384,302	–	–	0.11%	203
2025 Q1	$14.9M	Hold	384,302	–	–	0.14%	174
2024 Q4	$13M	Sell	384,302 -1,634,890	-81%	-$58.9M	0.11%	188
2024 Q3	$82.5M	Sell	2,019,192 -1,312,266	-39%	-$53.7M	0.66%	23
2024 Q2	$128M	Buy	3,331,458 +2,099,175	+170%	+$88.3M	1.08%	9
2024 Q1	$52.8M	Buy	+1,232,283	New	+$50.8M	0.54%	34
2023 Q3	–	Sell	-10,000	Closed	-$356K	–	978
2023 Q2	$356K	Hold	10,000	–	–	﹤0.01%	532
2023 Q1	$356K	Sell	10,000 -108,571	-92%	-$3.8M	0.01%	772
2022 Q4	$4.17M	Sell	118,571 -228,280	-66%	-$7.6M	0.07%	306
2022 Q3	$10.2M	Buy	+346,851	New	+$13.1M	0.19%	128

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LMR Partners's GSK Position: Q1 2026 in Review

LMR Partners opened a new position in GSK (GSK) in Q1 2026: 980,479 shares worth $54.1M. The stake represents 0.12% of the portfolio and ranks #89 among its holdings. This is a return to the name: LMR Partners previously reported a position in GSK as recently as Q3 2025.

LMR Partners first reported a position in GSK in Q3 2022 and has held it in 12 quarters since. The position peaked at $128M in Q2 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

LMR Partners held 980,479 shares of GSK worth $54.1M as of Q1 2026.
GSK was a new LMR Partners position in Q1 2026.
GSK made up 0.12% of LMR Partners's portfolio in Q1 2026, its #89 holding.
LMR Partners first reported a position in GSK in Q3 2022 and has held it in 12 quarters since.
LMR Partners's GSK position peaked at $128M in Q2 2024.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.